Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS) (ENDORSE)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Biogen
ClinicalTrials.gov Identifier:
NCT00835770
First received: February 2, 2009
Last updated: November 3, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2023
  Estimated Primary Completion Date: February 2023 (Final data collection date for primary outcome measure)